Because of its structural and functional characteristics, BBB “shuts down” several drugs used to treat neurological diseases (Zlokovic, 2008; Abbott and Friedman, 2012), such as exogenous nerve growth factor (NGF), which becomes a major obstacle during treatment (Miller, 2010; Mahringer et al., 2011). The gene discussed is NGF; the disease is nervous system disorder.